Lu, J. and Greco, M. A. Sleep circuitry and the hypnotic mechanism of GABAA drugs. J.Clin.Sleep Med. 4-15-2006;2(2):S19-S26. View abstract.
Meldrum, B. S. GABAergic mechanisms in the pathogenesis and treatment of epilepsy. Br.J.Clin.Pharmacol. 1989;27 Suppl 1:3S-11S. View abstract.
Ozdemir, C., Schneider, L. A., Hinrichs, R., Staib, G., Weber, L., Weiss, J. M., and Scharffetter-Kochanek, K. [Allergic contact dermatitis to common ivy (Hedera helix L.)]. Hautarzt 2003;54(10):966-969. View abstract.
Amara-Mokrane YA, Lehucher-Michel MP, Balansard G, et al. Protective effects of alpha-hederin, chlorophyllin and ascorbic acid towards the induction of micronuclei by doxorubicin in cultured human lymphocytes. Mutagenesis 1996;11:161-7. View abstract.
Boyle J, Harman RM. Contact dermatitis to Hedera helix (common ivy). Contact Dermatitis 1985;12(2):111-112. View abstract.
Bregnbak D, Menné T, Johansen JD. Airborne contact dermatitis caused by common ivy (Hedera helix L. ssp. helix). Contact Dermatitis. 2015;72(4):243-4. View abstract.
Fazio S, Pouso J, Dolinsky D, et al. Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. Phytomedicine 2009;16(1):17-24. View abstract.
Gaillard Y, Blaise P, Darre A, Barbier T, Pepin G. An unusual case of death: suffocation caused by leaves of common ivy (Hedera helix). Detection of hederacoside C, alpha-hederin, and hederagenin by LC-EI/MS-MS. J Anal Toxicol 2003;27(4):257-262. View abstract.
García M, Fernández E, Navarro JA, et al. Allergic contact dermatitis from Hedera helix L. Contact Dermatitis 1995;33(2):133-4. View abstract.
Gulcin I, Mshvildadze V, Gepdiremen A, Elias R. Antioxidant activity of saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F. Planta Med 2004;70(6):561-563. View abstract.
Gulyas A, Repges R, Dethlefsen U. Therapy of chronic obstructive pulmonary diseases in children (Translation). Atemvegs und Lungenkrankheiten 1997;23:291-4.
Hausen BM, Brohan J, Konig WA, et al. Allergic and irritant contact dermatitis from falcarinol and didehydrofalcarinol in common ivy (Hedera helix L.). Contact Dermatitis 1987;17(1):1-9. View abstract.
Hocaoglu AB, Karaman O, Erge DO, et al. Effect of Hedera helix on lung histopathology in chronic asthma. Iran J Allergy Asthma Immunol. 2012;11(4):316-23. View abstract.
Johnke H, Bjarnason B. [Contact dermatitis allergy to common ivy (Hedera helix L.)]. Ugeskr Laeger 1994;156(25):3778-3779. View abstract.
Jones JM, White IR, White JM, McFadden JP. Allergic contact dermatitis to English ivy (Hedera helix)--a case series. Contact Dermatitis. 2009 Mar;60(3):179-80. View abstract.
Lässig W, Generlich G, Heydolph F, Paditz E. Efficacy and tolerability of ivy-containing cough remedies. TW Pediatr 1996;9:489-491.
Lurquin E, Swinnen I, Goossens A. Allergic contact dermatitis caused by Hedera helix arborescens and not by Hedera helix L. Contact Dermatitis. 2012;66(6):352-3. View abstract.
Mitchell, J. C. Allergic contact dermatitis from Hedera helix and Brassaia actinophylla (Araliaceae). Contact Dermatitis 1981;7(3):158-159. View abstract.
Paulsen E, Christensen LP, Andersen KE. Dermatitis from common ivy (Hedera helix L. subsp. helix) in Europe: past, present, and future. Contact Dermatitis. 2010;62(4):201-9. View abstract.
Rehman SU, Kim IS, Choi MS, Kim SH, Zhang Y, Yoo HH. Time-dependent Inhibition of CYP2C8 and CYP2C19 by Hedera helix Extracts, A Traditional Respiratory Herbal Medicine. Molecules. 2017;22(7). View abstract.
Villani P, Orsiere T, Sari-Minodier I, Bouvenot G, Botta A. [In vitro study of the antimutagenic activity of alphahederin]. Ann Biol Clin (Paris) 2001;59(3):285-289. View abstract.
Yesudian PD, Franks A. Contact dermatitis from Hedera helix in a husband and wife. Contact Dermatitis 2002;46(2):125-126. View abstract.